SEZARY SYNDROME

Clinical trials for SEZARY SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SEZARY SYNDROME trials appear

Sign up with your email to follow new studies for SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 3 Not yet finished but already full! 6 Terminated 1

Promising lymphoma combo trial halted after just 8 patients

Disease control Terminated

This early-phase trial tested two lab-made antibodies, magrolimab and mogamulizumab, together in people with a type of T-cell lymphoma (mycosis fungoides or Sezary syndrome) that had returned or stopped responding to prior treatments. The goal was to find the best dose and see if…

Matched conditions: SEZARY SYNDROME

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

SEZARY SYNDROME

Get alerted when new SEZARY SYNDROME trials appear

Promising lymphoma combo trial halted after just 8 patients